课题基金 / 基金详情

Triple Targeted Kinase Inhibitors Capable of Inhibiting Breast Cancer Metastases

Triple Targeted Kinase Inhibitors Capable of Inhibiting Breast Cancer Metastases
能够抑制乳腺癌转移的三靶向激酶抑制剂
批准号：
227961
负责人：
Alaoui-Jamali Moulay A
金额：
$11.66万
依托单位：
CIUSSS de Centre-Ouest-de-l'Ile-de-Montral-Jewish General
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2011
资助国家：
加拿大
项目状态：
已结题
起止时间：
2011-02-01 至 2012-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=227961&lang=en
关键词：
Breast Cancer Investigational Drugs Metastasis Pharmacology Preclinical Cancer Models Structure-Activity

项目摘要

项目成果

Alaoui-Jamali Moulay A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Metastatic breast cancer is common in oncology practice and represents a major cause of morbidity and mortality in women with breast cancer. Despite a good progress in the discovery of novel targeted therapies, most metastatic breast cancers remain incura
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterization and therapeutic implication of a novel class of PKC-theta inhibitors selectively targeting undifferentiated cancer cells expressing stem cell markers
Investigation of the Filamin Signaling Network's Function in Cancer Progression
Molecular and Translational Studies of Filamin Signaling Network in Invasive Cancer
Discovery and Validation of Pharmacological Probes for Understanding Protein-Protein Interactions of Focal Adhesion Signalling in Invasive Cancer Cells
海外基金